University of Oxford have developed short peptides able to bind and neutralise the chemokine signalling network involved in inflammation. The peptides were developed from naturally occurring tick salivary proteins and functionalised using a rational drug design approach. Multi/Pan-chemokine inhibition aims to selectively inhibit pathological (autoimmune and) inflammatory responses without compromising wider immunity.
Take a look at the finalists across the four competition categories
Find out more